IBB vs IHI: Holdings Overlap & Returns
Over the year to Nov 13, 2026, IBB returned +30.4% to IHI's −7.4%; 0% of their weight is in the same names.
- Return gap
- +37.8 pts1 year to Nov 13, 2026: IBB ahead, total return
- Fee gap
- 0.07 ptsA year: IBB 0.44%, IHI 0.37%, per filings dated Jul 27, 2026
- Overlap
- 0%Share of the two books held in common, holdings dated Nov 12, 2026
- Net flow
- −$50m / +$76mIBB / IHI, Oct 13, 2026 to Nov 12, 2026, daily basis
Compare two other funds
Growth of 100
Drawn from the numbers on this page. Growth of 100, both funds, distributions reinvested
IBB +30.4%, IHI −7.4%: IBB +37.8 pts ahead, 1 year, Nov 13, 2025 to Nov 13, 2026.
ShareUse this comparison
Client brief:
The two-page PDF for this pair is coming. Save the comparison to follow its changes. Free. It needs an email sign-in, once.
Cost to trade
Hypothetical. A $10,000 order in IBB costs about $2.00 one way and $4.00 in and out, at a median spread of 0.04%. The 0.04% spread is IBB’s 30-day median, from iShares (fund page).
Fees over time
Hypothetical. $10,000 in IBB for 10 years at 0.44% a year costs about $730 in fees and lost growth; IHI at 0.37% would cost $615. Assumes 6% a year before fees, a sample rate, not a forecast.
How each fund moved
43% of IBB's weight is in S&P 500 companies and 57% is outside the index. Holdings as of Nov 12, 2026.
89% of IHI's weight is in S&P 500 companies and 12% is outside the index. Holdings as of Nov 12, 2026.
Key numbers
IHI costs 0.07 points a year less; their one-year returns differ by 37.8 points; IBB is 2.8 times larger.
Pair scorecard
Open the table
Points (pts) are percentage points.
| Total return, 1 year | +30.4% | −7.4% |
|---|---|---|
| Below its all-time high | 11.5%, high on Sep 8, 2021 | |
| What it tracks | Biotech | Therapeutics and medical devices |
| Expense ratio | 0.44% | 0.37% |
| Net assets, as of Nov 12, 2026 | $11.1bn | $4.0bn |
| Holdings in common | 0% |
The numbers behind it
Net assets: $11.1bn on Nov 12, 2026 for iShares Biotechnology ETF, and $4.1bn on Nov 13, 2026 for iShares U.S. Medical Devices ETF.
Holdings in common uses holdings dated Nov 12, 2026.
What they share
By the books each fund has filed, IBB and IHI hold 0% of their money in the same securities at the same weight. Holdings dated Nov 12, 2026.
half
0% in common
Held in common
Show all 2 holdings
| NOVOCURE | 0.08% | 0.16% |
| E-MINI HEALTH CARE SECTOR DEC 26 | 0.00% | 0.00% |
Only in IBB
Show all 8 holdings
| GILEAD SCIENCES | 8.96% |
| AMGEN INC | 8.48% |
| VERTEX PHARMACEUTICALS | 7.78% |
| REGENERON PHARMACEUTICALS | 6.51% |
| MODERNA | 5.84% |
| ARGENX SE ADR | 3.77% |
| NATERA | 3.00% |
| BIOGEN | 2.54% |
Only in IHI
Show all 8 holdings
| ABBOTT LABORATORIES | 17.27% |
| INTUITIVE SURGICAL | 14.46% |
| MEDTRONIC PLC | 11.51% |
| IDEXX LABORATORIES | 5.48% |
| EDWARDS LIFESCIENCES | 4.96% |
| BECTON DICKINSON AND CO | 4.85% |
| GE HEALTHCARE TECHNOLOGIES | 4.63% |
| STRYKER | 4.59% |
Side by side
Open the table
| Fund | iShares Biotechnology ETF · Holds 245 stocks in biotech, 43% of its weight in S&P 500 companies | iShares U.S. Medical Devices ETF · Holds 51 stocks in therapeutics and medical devices, 88% of its weight in S&P 500 companies |
| Issuer | iShares | iShares |
| Theme | Biotech | Therapeutics and medical devices |
| In the S&P 500 | 42.6% | 88.5% |
| Active share vs the S&P 500 | 99.0% | 98.7% |
| In the Nasdaq-100 | 33.2% | 28.4% |
| Holdings | 245 | 51 |
| Top ten, share of the fund | 51.6% | 76.0% |
| Expense ratio | 0.44% | 0.37% |
| Fee for the differing part | 0.44% | 0.37% |
| Total return, 1 year | +30.4% | −7.4% |
| vs its benchmark | not measured | not measured |
| Below its high | −3.9% | −11.5% |
| Net assets, IBB as of Nov 12, 2026 and IHI as of Nov 13, 2026 | $11.1bn | $4.1bn |
As of Nov 13, 2026. Source: ETFIQ.
Window by window
Open the table
| 3 months | +7.2% | +4.2% |
|---|---|---|
| 6 months | +27.4% | +20.1% |
| 1 year | +30.4% | −7.4% |
| 3 years | +81.5% | +23.4% |
| Since launch (Not the same days: IBB Feb 2001 · IHI May 2006) | +543.4% | +658.0% |
From Jan 2010 to Nov 2026, IBB returned more: +688.1% to +585.6%. IHI swung less: 18.2% to 22.6%. IHI fell less at its worst: −32.7% to −37.5%.
Full scorecard
Open the table
| Total return | +688.1% | +585.6% | IBB | Price change plus distributions, reinvested. |
| Annualized | +13.0% | +12.1% | IBB (slight) | Total return as a yearly rate. |
| Price return | +657.0% | +534.9% | IBB | Price change alone, distributions left out. |
| Volatility | 22.6% | 18.2% | IHI | Spread of weekly returns, annualized. Lower is steadier. |
| Downside deviation | 15.5% | 12.5% | IHI | Like volatility, counting only weeks below the Treasury bill rate. |
| Max drawdown | −37.5% | −32.7% | IHI | Deepest fall from a high to the low after it. |
| Sharpe | 0.59 | 0.63 | IHI (slight) | Return above Treasury bills per unit of volatility. |
| Sortino | 0.86 | 0.92 | IHI (slight) | Return above Treasury bills per unit of downside deviation. |
| Calmar | 0.35 | 0.37 | IHI (slight) | Annualized return divided by the max drawdown. |
More
Computed by ETFIQ from Tiingo daily prices and ETFIQ's distribution records, 878 weekly returns. Cash rate: the 13-week Treasury bill.
About IBB
By weight, 43% of IBB's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 52% of the fund across 245 positions, as published by its issuer for Nov 12, 2026.
More
Over the year to Nov 13, 2026 the fund returned +30.4% with distributions reinvested.
About IHI
By weight, 88% of IHI's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 76% of the fund across 51 positions, as published by its issuer for Nov 12, 2026.
More
Over the year to Nov 13, 2026 the fund returned −7.4% with distributions reinvested. It sits 11.5% below its all-time high of Sep 8, 2021.
0% of the two portfolios are the same securities at the same weight.
Questions people ask
Do IBB and IHI hold the same stocks?
By their latest filings, 0% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.
Other comparisons
Sources
More
Links are sources, not endorsements. A comparison is not a recommendation.
Copy and cite
Cite this pageCitation, APA and Markdown
ETFIQ, IBB against IHI, data as of Nov 13, 2026. https://etfiq.com/compare/themes/ibb-vs-ihi
ETFIQ. (Nov 13, 2026). IBB against IHI. Retrieved from https://etfiq.com/compare/themes/ibb-vs-ihi
[IBB against IHI (ETFIQ, Nov 13, 2026)](https://etfiq.com/compare/themes/ibb-vs-ihi)
Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.